If you choose to keep it in the fridge after the first use, it still must be discarded after those 56 days have passed
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
However, some patients may experience a rapid progression over several days
Tirzepatide, the first dual GIP and GLP-1 receptor agonist, is in keeping with these conceptions
The available injection sites for subcutaneous administration are the abdomen, the upper arm or the upper thigh
Some of these products are said to improve the secretion of the GLP-1 hormone produced by the body, which in turn might help in reducing appetite and cravings, managing blood sugar level and helping in weight management